Interestingly, naïve Crebbp+/- mice developed MDS/MPN-U around 9–12 months of age, which progressed to AML in ~40% of the cases [2, 14]. This evidence concerns the gene CREBBP and myeloproliferative neoplasm, unclassifiable.